← Open Payments lookup

KERRI MAXCY: Open Payments

NPI 1255711768 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,166 in 65 payments from 15 companies in 2025. Trend: 2023 $862 · 2024 $1,249 · 2025 $1,166

Food & beverage: $1,166
CompanyPaymentsAmount
PFIZER INC.18$262
ABBVIE INC.13$171
AstraZeneca Pharmaceuticals LP5$146
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$121
Abbott Laboratories2$82
GlaxoSmithKline, LLC.4$70
Novo Nordisk Inc3$66
Lilly USA, LLC3$56
Otsuka America Pharmaceutical, Inc.2$56
Corcept Therapeutics3$43

Products named: CAPLYTA, BREZTRI, PREVNAR 20, VRAYLAR, FREESTYLE LIBRE 3, NURTEC ODT, ELIQUIS, MOUNJARO.

Industry payments across KS — which companies pay providers there.